Compare Repligen Corporation Common Stock (RGEN) vs Utilities Select Sector SPDR Fund (XLU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Repligen Corporation Common Stock vs Utilities Select Sector SPDR Fund — how do they compare? Repligen Corporation Common Stock trades at $178.15 (market cap $11.14B), while Utilities Select Sector SPDR Fund trades at $41.9 (market cap $24.20B). The key difference: Utilities Select Sector SPDR Fund is far larger — about 2.2× Repligen Corporation Common Stock's market cap, and Repligen Corporation Common Stock is trading nearer its 52-week high, Utilities Select Sector SPDR Fund nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Repligen Corporation Common Stock for 0 Days and Utilities Select Sector SPDR Fund for 81 Days on average.
| RGEN | XLU | |
|---|---|---|
Market Cap | $11.14B | $24.20B |
Volume | 1,259,263 | 27,226,247 |
Sector | Health | — |
52-Week High | $194.57 | $47.73 |
52-Week Low | $102.87 | $39.25 |
Typical Hold Time | 0 Days | 81 Days |
Enterprise Value | $11.02B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
RGEN trades at $175.42, up 1.66% today, with a neutral technical signal and key support at $173. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 27. Revenue grew to $738.26M in 2025, though net income margin is modest at 5.29%. The company recently completed the acquisition of BioLife Solutions, signaling strategic expansion.
Outlook remains positive with strong analyst support (91.67% buy ratings) and a consensus price target of $173.86, though high valuation multiples (P/E 240.34) pose a risk. Earnings growth and integration of acquisitions are key catalysts, but investors face execution risks and market volatility.
XLU trades at $41.87, up 0.58% on the day, but remains under pressure after hitting recent 52-week lows near $39.13. Technical indicators show mixed signals with a bullish moving average trend but bearish oscillators, including an overbought RSI. The utilities sector faces headwinds from rising interest rates and regulatory challenges, particularly affecting data-center demand growth.
The outlook remains cautious as utility stocks face macro pressures from interest rates and regulatory uncertainty. While defensive characteristics provide some stability, near-term performance depends on interest rate direction and AI power demand evolution. Risk-reward appears balanced with potential for recovery if macro conditions stabilize.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Repligen Corporation Common Stock
Repligen Corporation develops and manufactures bioprocessing tools and technologies used in biologic drug manufacturing, including filtration and perfusion systems, chromatography columns and resins, and process analytics instruments. Its products support upstream and downstream production workflows for modalities such as monoclonal antibodies, mRNA, and viral vectors.
Read more on RGEN →About Utilities Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes securities of companies from the following industries: electric utilities; water utilities; multi-utilities; independent power and renewable electricity producers; and gas utilities. The fund is non-diversified.
Read more on XLU →
